Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001121781-10-000203
Filing Date
2010-05-03
Accepted
2010-05-03 17:21:03
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 RADIENT PHARMACEUTICALS CORPORATION rpc10ka123109.htm 10-K/A 2036502
2 CERTIFICATION ex31one.htm EX-31.1 15510
3 CERTIFICATION ex31two.htm EX-31.2 15365
4 CERTIFICATION ex32one.htm EX-32.1 8474
5 CERTIFICATION ex32two.htm EX-32.2 8402
6 COMMERCIAL LEASE ex10_54.htm EX-10.54 153382
7 COLLABORATION AGREEMENT ex10_55.htm EX-10.55 152883
8 EXCLUSIVE DISTRIBUTION AGREEMENT ex10_56.htm EX-10.56 141165
9 DISTRIBUTION AGREEMENT ex10_57.htm EX-10.57 144781
10 ex10_570.jpg GRAPHIC 278472
11 ex10_571.jpg GRAPHIC 227755
  Complete submission text file 0001121781-10-000203.txt   3375999
Mailing Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780
Business Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780 7145054460
RADIENT PHARMACEUTICALS Corp (Filer) CIK: 0000838879 (see all company filings)

EIN.: 330413161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16695 | Film No.: 10794033
SIC: 2834 Pharmaceutical Preparations